首页> 美国卫生研究院文献>Elsevier Sponsored Documents >A Phase III open-label randomized active controlled clinical study to assess safety immunogenicity and lot-to-lot consistency of a bovine-human reassortant pentavalent rotavirus vaccine in Indian infants

【2h】

A Phase III open-label randomized active controlled clinical study to assess safety immunogenicity and lot-to-lot consistency of a bovine-human reassortant pentavalent rotavirus vaccine in Indian infants

机译：一项III期开放标签随机主动控制的临床研究旨在评估印度婴儿牛-人重配五价轮状病毒疫苗的安全性免疫原性和批次间一致性

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

BackgroundA heat-stable bovine-human rotavirus reassortant pentavalent vaccine (BRV-PV, ROTASIIL®) was developed in India. In this study, the vaccine was tested for safety, immunogenicity and clinical lot-to-lot consistency.

机译：背景技术在印度开发了一种热稳定的牛-人轮状病毒重配五价疫苗（BRV-PV，ROTASIIL®）。在这项研究中，测试了疫苗的安全性，免疫原性和临床批次间一致性。

著录项

期刊名称 Elsevier Sponsored Documents
作者
Niraj Rathi; Sajjad Desai; Anand Kawade; Padmasani Venkatramanan; Ritabrata Kundu; Sanjay K. Lalwani; A.P. Dubey; J. Venkateswara Rao; D. Narayanappa; Radha Ghildiyal; Nithya Gogtay; P. Venugopal; Sonali Palkar; Renuka Munshi; Gagandeep Kang; Sudhir Babji; Ashish Bavdekar; Sanjay Juvekar; Nupur Ganguly; Prabal Niyogi; Kheya Ghosh Uttam; H.S. Rajani; Alpana Kondekar; Dipti Kumbhar; Smilu Mohanlal; Mukesh C Agarwal; Parvan Shetty; Kalpana Antony; Bhagwat Gunale; Abhijeet Dharmadhikari; Yuxiao Tang; Prasad S. Kulkarni; Jorge Flores;
展开▼
作者单位

展开▼
年(卷),期 -1(36),52
年度 -1
页码 7943–7949
总页数 7
原文格式 PDF
正文语种
中图分类
关键词
Bovine-Human Reassortant Pentavalent Rotavirus Vaccine (BRV-PV) Lot-to-Lot Consistency Immunogenicity Safety;

机译：牛-人类重配五价轮状病毒疫苗（BRV-PV）;批次对批次一致;免疫原性;安全性;

相似文献

外文文献
中文文献

1. Response to: A Phase III open-label, randomized, active controlled clinical study to assess safety, immunogenicity and lot-to-lot consistency of a bovine-human reassortant pentavalent rotavirus vaccine in Indian infants [J] . Vaccine . 2019,第23期

机译：回应：III期开放标签，随机的，活性受控临床研究，评估印度婴儿牛牛重新排列的牛身疫苗的安全性，免疫原性和批量达到批次
2. A Phase III open-label, randomized, active controlled clinical study to assess safety, immunogenicity and lot-to-lot consistency of a bovine-human reassortant pentavalent rotavirus vaccine in Indian infants [J] . Rathi Niraj, Desai Sajjad, Kawade Anand, Vaccine . 2018,第52期

机译：III期开放标签，随机，活性受控临床研究，以评估印度婴儿的牛牛身重新排列的牛身疫苗的安全性，免疫原性和批量批次
3. Immunogenicity and lot-to-lot consistency of a ready to use liquid bovine-human reassortant pentavalent rotavirus vaccine (ROTASIIL - Liquid) in Indian infants [J] . Vaccine . 2019,第19期

机译：在印度婴儿中，可以使用液体牛牛重新排列的五价甲状腺素疫苗（Rotasiil - 液体）的免疫原性和批量批量稠度
4. A randomized Phase III clinical trial to assess the efficacy of a bovine-human reassortant pentavalent rotavirus vaccine in Indian infants [O] . Prasad S. Kulkarni, Sajjad Desai, Tushar Tewari, -1

机译：一项随机的III期临床试验评估牛-人重配五价轮状病毒疫苗在印度婴儿中的功效
5. A phase III single arm, multicenter, open-label study to assess the immunogenicity and tolerability of a pentavalent DTwP–HepB–Hib vaccine in indian infants [O] . Adarsh Eregowda, Sanjay Lalwani, Sukanta Chatterjee, 2013

机译：III期单臂，多中心，开放标签研究，以评估印度婴儿五价DTWP-HEPB-HIB疫苗的免疫原性和耐受性
6. Randomized Double-Blind Phase III Pivotal Field Trial of the Comparative Immunogenicity Safety and Tolerability of Two Yellow Fever 17D Vaccines (ARILVAX(Trademark) and YF-VAX(Trademark)) in Healthy Infants and Children in Peru [R] . Belmusto-Worn, V. E. , Sanchez, J. L. , McCarthy, K. , 2004

机译：秘鲁健康婴儿和儿童两种黄热病17D疫苗（aRILVaX（商标）和YF-VaX（商标））的比较免疫原性安全性和耐受性的随机双盲III期关键现场试验

A Phase III open-label randomized active controlled clinical study to assess safety immunogenicity and lot-to-lot consistency of a bovine-human reassortant pentavalent rotavirus vaccine in Indian infants

摘要

著录项

相似文献

相关主题

期刊订阅